BNP/CALL/MERCK & CO./120/0.1/16.01.26 Share Price

Warrant

DE000PC1LL26

Market Closed - Börse Stuttgart 08:12:51 05/07/2024 BST
1.79 EUR -1.10% Intraday chart for BNP/CALL/MERCK & CO./120/0.1/16.01.26
Current month-17.51%
1 month-11.82%
Date Price Change
05/07/24 1.79 -1.10%
04/07/24 1.81 -9.95%
03/07/24 2.01 +3.08%
02/07/24 1.95 +11.43%
01/07/24 1.75 -19.35%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 08:12 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1LL2
ISINDE000PC1LL26
Date issued 11/12/2023
Strike 120 $
Maturity 16/01/2026 (558 Days)
Parity 10 : 1
Emission price 0.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.36
Lowest since issue 0.76
Spread 0.02
Spread %1.08%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus